Prospective Validation of the Movement Disorder Society Prodromal Multiple System Atrophy Criteria in Pure Autonomic Failure
Movement Disorders · 2026
DOI: 10.1002/mds.70417 ↗Kurz gefasst
Validierungsstudie in der Zeitschrift Movement Disorders, 2026. Verfasst von Patricio Millar Vernetti und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, New York University Grossman School of Medicine, New York, NY, USA. Hauptthemen laut MEDLINE: Multiple System Atrophy, Pure Autonomic Failure. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 26 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NINDS NIH HHS, The Algard Family MSA Innovation Fund, NIH HHS.
Abstract (Originalsprache)
Background
The Movement Disorder Society (MDS) research criteria for possible prodromal multiple system atrophy (PP‐MSA) have not been prospectively validated.
Objective
To evaluate the diagnostic performance of the PP‐MSA criteria in a longitudinal cohort of patients with pure autonomic failure (PAF) and to assess whether additional clinical features improve their predictive value.
Methods
Seventy‐six patients with PAF enrolled across eight centers in the Natural History Study of the Synucleinopathies were followed for ≥6 years or until phenoconversion. Participants were classified according to MDS PP‐MSA criteria and followed for development of MSA, Parkinson's disease, or dementia with Lewy bodies. Diagnostic performance was assessed longitudinally. Analyses were repeated using a stricter olfactory threshold (University of Pennsylvania Smell Identification Test [UPSIT]≤28) as an exclusion criterion.
Results
Thirty‐eight participants met PP‐MSA criteria, of whom 12 phenoconverted to MSA within 6 years. Sensitivity was 100% at year 1 and 92% at year 6, whereas specificity ranged from 56% to 67%. Positive predictive value (PPV) ranged from 21% to 34%. Applying a stricter olfactory threshold improved specificity (90%–97%) and PPV (53%–83%), with a modest reduction in sensitivity (to 83%). Participants who phenoconverted to MSA were younger, had more severe urinary dysfunction, and greater orthostatic heart rate responses.
Conclusions
The PP‐MSA criteria demonstrate high sensitivity but limited specificity in patients with PAF. A stricter olfactory threshold improves diagnostic performance and may enhance cohort enrichment for clinical trials. © 2026 International Parkinson and Movement Disorder Society. This article has been contributed to by U.S. Government employees and their work is in the public domain in the USA.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Neurology, New York University Grossman School of Medicine, New York, NY, USA.
- Department of Medicine, Vanderbilt University Medical Center, Nashville, TN, USA.
- Department of Neurology, Brigham and Women's Hospital, Harvard University, Boston, MA, USA.
- Department of Neurology, Mayo Clinic Rochester, Rochester, MN, USA.
- Department of Neurology, Stanford University, Stanford, CA, USA.
- Department of Neurology, Medical University Innsbruck, Innsbruck, Austria.
ORCID-Profile: Patricio Millar Vernetti, Jose-Alberto Palma, Italo Biaggioni, Cyndya A Shibao, Roy Freeman, Christopher Gibbons, Wolfgang Singer, Elizabeth A Coon, Mitchell G Miglis, Florian Krismer, Alessandra Fanciulli, David S Goldstein, Rebecca A Betensky, Horacio Kaufmann
Förderung
- NINDS NIH HHS
- The Algard Family MSA Innovation Fund
- NIH HHS
- National Institutes of Health
Zitieren
APA
Millar Vernetti, P., Palma, J. A., Biaggioni, I., Shibao, C. A., Freeman, R., Gibbons, C., Singer, W., Coon, E. A., Miglis, M. G., Krismer, F., Fanciulli, A., Goldstein, D. S., Betensky, R. A., & Kaufmann, H. (2026). Prospective Validation of the Movement Disorder Society Prodromal Multiple System Atrophy Criteria in Pure Autonomic Failure. Movement Disorders. https://doi.org/10.1002/mds.70417
Vancouver
Millar Vernetti P, Palma JA, Biaggioni I, Shibao CA, Freeman R, Gibbons C, et al. Prospective Validation of the Movement Disorder Society Prodromal Multiple System Atrophy Criteria in Pure Autonomic Failure. Movement Disorders. 2026. doi:10.1002/mds.70417
BibTeX
@article{MillarVernetti2026,
author = {Millar Vernetti, Patricio and Palma, Jose-Alberto and Biaggioni, Italo and Shibao, Cyndya A and Freeman, Roy and Gibbons, Christopher and Singer, Wolfgang and Coon, Elizabeth A and Miglis, Mitchell G and Krismer, Florian and Fanciulli, Alessandra and Goldstein, David S and Betensky, Rebecca A and Kaufmann, Horacio},
title = {Prospective Validation of the Movement Disorder Society Prodromal Multiple System Atrophy Criteria in Pure Autonomic Failure},
journal = {Movement Disorders},
year = {2026},
doi = {10.1002/mds.70417}
}
EUVIMED